VCT220
A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population
Vincentage Pharma Co · Phase 2 · Completed · Enrollment 250
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 80mg dose group | Obesity or overweight | 80mg | 3 | n/r | n/r |
| 120mg dose group | Obesity or overweight | 120mg | 3 | n/r | n/r |
| 160mg dose group fast titration | Obesity or overweight | 160mg | 3 | n/r | n/r |
| 160mg dose group slow titration | Obesity or overweight | 160mg | 3 | n/r | n/r |